tiprankstipranks
Apellis Pharmaceuticals (APLS)
NASDAQ:APLS
US Market
APLS
Apellis Pharmaceuticals
RESEARCH TOOLSreports
Want to see APLS full AI Analyst Report?

Apellis Pharmaceuticals (APLS) Income Statement

1,012 Followers

Apellis Pharmaceuticals Income Statement

Last quarter (Q4 2025), Apellis Pharmaceuticals's total revenue was $199.91M, a decrease of -5.94% from the same quarter last year. In Q4, Apellis Pharmaceuticals's net income was $-58.95M. See Apellis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.00B$ 781.37M$ 396.59M$ 75.42M$ 66.56M
Gross Profit
$ 901.55M$ 663.64M$ 338.08M$ 69.79M$ 61.36M
Operating Expenses
$ 846.12M$ 828.62M$ 855.20M$ 664.40M$ 597.64M
Depreciation and Amortization
$ 1.56M$ 1.80M$ 1.70M$ 1.49M$ 1.49M
EBITDA
$ 70.00M$ -154.53M$ -495.21M$ -617.39M$ -731.27M
Operating Income
$ 55.43M$ -164.98M$ -517.12M$ -594.61M$ -536.28M
Other Income/Expenses
$ -31.32M$ -31.74M$ -9.38M$ -56.89M$ -209.72M
Pretax Income
$ 24.11M$ -196.72M$ -526.50M$ -651.50M$ -746.00M
Net Income
$ 22.39M$ -197.88M$ -528.63M$ -652.17M$ -746.35M
Per Share Metrics
Basic EPS
$ 0.18$ -1.60$ -4.45$ -6.15$ -8.84
Diluted EPS
$ 0.18$ -1.60$ -4.45$ -6.15$ -8.84
Weighted Average Shares Outstanding
 126.02M 123.91M 118.68M 106.11M 84.42M
Weighted Average Shares Outstanding (Diluted)
 126.02M 123.91M 118.68M 106.11M 84.42M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History